ACL vs GSS

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

53MEDIUM

GSS

GENETICSIG FPO [GSS]

54MEDIUM

Score Breakdown

ACL GSS
Technical
62
50
Catalyst
88
65
Sentiment
50
50
Fundamental
67
59
Momentum
47
31
Risk Gate
36
50

Key Metrics

ACL Metric GSS
$423.4MMarket Cap$14.5M
520KAvg Volume (20d)877K
+7.3%Short InterestN/A
$2.97052-Week High$0.430
$1.83352-Week Low$0.057
+2.0%Daily Change-1.6%
$2.275Reference Price$0.063
+16.7%ROE-22.8%
+3.6%Profit Margin-56.5%

Active Signals

ACL Signals

Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Trading above both moving averages — the trend is your friend here
Above-average volume (1.7x) on a green day — buyers stepping up
Knocking on the door of resistance — if it punches through, things could get interesting
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)

GSS Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (12 quarters)
Low P/S ratio (0.7x)
EPS estimates revised downward (-10pts)
Near 52-week low (2% of range)

Ask Scout AI to compare ACL and GSS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ACL vs HIQ →ACL vs IBX →ACL vs IDT →ACL vs IDX →ACL vs IMR →
ACL Full Analysis → GSS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).